FDA Approved: MAYZENT — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approves Mayzent (siponimod) from Novartis Pharmaceuticals Corporation in an original NDA for the treatment of relapsing forms of multiple sclerosis. This a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Progressive Multiple Sclerosis
• Relapsing Forms of Multiple Sclerosis

Drugs mentioned

• MAYZENT (siponimod)

Snippet

ORIG AP for MAYZENT (SIPONIMOD)